retatrutide clinical trial results weight loss retatrutide (“reta”) is an experimental weight-loss drug currently in Phase 3 trials. It's a once-weekly injection similar to Ozempic and Mounjaro—but more powerful. The reason comes down to how it works Size:20 Servings People who stop weight 1166C

retatrutide clinical trial results weight loss retatrutide (“reta”) is an experimental weight-loss drug currently in Phase 3 trials. It's a once-weekly injection similar to Ozempic and Mounjaro—but more powerful. The reason comes down to how it works Size:20 Servings People who stop weight 1166C

People who stop weight loss drugs return to original weight within year, analysis finds | Health | The Guardian

But in exercise, similar increases lead to beneficial athletic cardiac remodeling

1166C

Size:20 Servings

The failure of both Pfizer oral GLP-1 candidates underscored the difficulty of the small-molecule approach and left orforglipron as the only advanced oral non-peptide GLP-1 agonist in clinical development